Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Leidos Assembles Supply Chain for LCCM and AGM-190A Production

Leidos issued an 8-K press release on November 2, 2026, disclosing a supplier summit and production plans for its Low-Cost Containerized Missile and the AGM-190A Havoc Spear cruise missile.

Aakashdeep | 02 November 2026

Pampa Energia Q3 2026 Sales Rise 34% to $790 Million

Pampa Energia S.A. released its third-quarter and nine-month 2026 earnings results on November 2, 2026, reporting financial and operational performance for the period ended September 30, 2026.

Nitish Kishor | 02 November 2026

MSA Safety Q3 2026: Net Sales Rise 15% After Autronica Deal

MSA Safety Incorporated filed an 8-K earnings release on November 2, 2026, reporting financial results for the third quarter ended September 30, 2026, including the completed acquisition of Autronica Fire and Security.

Shwetambri Chauhan | 02 November 2026

Bitmine Reports 6.06M ETH Holdings Worth $14.5B

Bitmine Immersion Technologies, Inc. filed an 8-K style press release on November 2, 2026, disclosing that its total crypto holdings, liquid securities, and "moonshot" investments reached $14.5 billion as of November 1, 2026.

Shwetambri Chauhan | 02 November 2026

Bigger Capital, Michael Bigger File 13G on Dermata Therapeutics

A Schedule 13G was filed with the SEC on November 2, 2026, by Bigger Capital Fund LP, its affiliates, and individual Michael Bigger, disclosing beneficial ownership positions in Dermata Therapeutics, Inc. (NASDAQ:DRMA) common stock as of September 30, 2026.

Anjali Anand | 02 November 2026

NexPoint NXDT Declares $0.34375 Preferred Dividend

NexPoint Diversified Real Estate Trust filed an 8-K on November 2, 2026, announcing a cash distribution of $0.34375 per share on its 5.50% Series A Cumulative Preferred Shares, payable December 31, 2026.

Shwetambri Chauhan | 02 November 2026

Frazier Life Sciences Cuts Phathom Stake to 6.5%

Frazier Life Sciences Public Fund, L.P. and related entities filed Amendment No. 12 to a Schedule 13D with the SEC on November 2, 2026, disclosing updated beneficial ownership positions in Phathom Pharmaceuticals, Inc. as of the triggering event date of October 29, 2026.

Shwetambri Chauhan | 02 November 2026

Carl K. Oppenheimer Discloses 5.1% Stake in SEACOR Marine

A Schedule 13G filed on November 2, 2026 discloses that Carl K. Oppenheimer and affiliated entities collectively hold a 5.1% beneficial ownership stake in SEACOR Marine Holdings Inc. as of September 30, 2026.

Aditi Sarkar | 02 November 2026

Robinhood Markets Files 13G on Ventures Fund II, 12% Stake

Robinhood Markets, Inc. filed a Schedule 13G with the SEC on November 2, 2026, disclosing beneficial ownership of 1,091,957 Common Shares of Beneficial Interest in Robinhood Ventures Fund II as of September 30, 2026.

Shwetambri Chauhan | 02 November 2026

JPMorgan 3-Year IBIT Barrier Notes Priced November 2026

JPMorgan Chase Financial Company LLC, guaranteed by JPMorgan Chase & Co., filed a free writing prospectus on November 2, 2026, disclosing the terms of its 3-year Capped Accelerated Barrier Notes linked to the iShares Bitcoin Trust ETF (IBIT), with a pricing date of November …

Anjali Anand | 02 November 2026
Support

Hi! How can we help you today?

Loading…